ONCOC4, INC.
Developing first-in-class medicines for hard-to-treat cancer and Alzheimer's disease
Rockville, United States · Founded 2021
- Headquarters
- Rockville, Maryland
- Founded
- 2021
- Business Model
- B2B
- Website
- oncoc4.com
About
OncoC4 is a clinical-stage biopharmaceutical company developing first-in-class and best-in-class medicines for hard-to-treat cancers and Alzheimer's disease. Leveraging innate and adaptive immune checkpoints—CTLA-4, PD-1/VEGF, CD24, and Siglec—the company engineers monoclonal antibodies, bispecific antibodies, and antibody-drug conjugates. Its lead program, gotistobart (BNT316/ONC-392), is being co-developed with BioNTech for immunotherapy-resistant non-small cell lung cancer and other advanced tumors.
Summary
ONCOC4, INC. is a Biotech company based in Rockville, United States, founded in 2021.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oncoc4-inc"><img src="https://indexed.vc/api/badge/company/oncoc4-inc" alt="ONCOC4, INC. on Indexed.vc" width="260" height="76" /></a>